UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053479
Receipt number R000056080
Scientific Title Effect of oral intake of branched-chain amino acids in nursing mothers on the concentration of glutamic acid in breast milk - leucine as a representative substance
Date of disclosure of the study information 2024/01/30
Last modified on 2024/01/30 17:48:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of oral intake of branched-chain amino acids in nursing mothers on the concentration of glutamic acid in breast milk - leucine as a representative substance

Acronym

Effect of oral intake of branched-chain amino acids in nursing mothers on the concentration of glutamic acid in breast milk - leucine as a representative substance

Scientific Title

Effect of oral intake of branched-chain amino acids in nursing mothers on the concentration of glutamic acid in breast milk - leucine as a representative substance

Scientific Title:Acronym

Effect of oral intake of branched-chain amino acids in nursing mothers on the concentration of glutamic acid in breast milk - leucine as a representative substance

Region

Japan


Condition

Condition

Breast-feeding Woman

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the effect of oral leucine intake on glutamate concentrations in milk and blood over time after oral leucine intake by lactating mothers.

Basic objectives2

Others

Basic objectives -Others

To clarify the relationship between physical information other than maternal diet and activity level, breastfeeding and infant information, and blood and milk glutamate concentrations.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Glutamic acid concentration in milk

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

With oral intake of leucine

Interventions/Control_2

No oral intake of leucine

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Female

Key inclusion criteria

Women between the ages of 20 and 39
Nursing mothers from 4 months to 18 months postpartum
Non-smokers
Womem who consume breakfast on a daily basis

Key exclusion criteria

Women who are allergic to the test food
Women with a history of endocrine disorders, breast disease, diabetes, dyslipidemia, cardiovascular disease, renal disease, liver disease and other diseases
Women who are prescribed any drugs that affect metabolism
Women who are currently pregnant

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Yumiko
Middle name
Last name Tateoka

Organization

Shiga University of Medical Science

Division name

Division of Maternity Nursing, Department of Clinical Nursing

Zip code

5202192

Address

Setatsukinowa-cho,Otsu-shi,Shiga

TEL

0775482433

Email

ytateoka@belle.shiga-med.ac.jp


Public contact

Name of contact person

1st name Yumiko
Middle name
Last name Tate

Organization

Shiga University of Medical Science

Division name

Division of Maternity Nursing, Department of Clinical Nursing

Zip code

5202192

Address

Setatsukinowa-cho,Otsu-shi,Shiga

TEL

0775482433

Homepage URL


Email

ytateoka@belle.shiga-med.ac.jp


Sponsor or person

Institute

Shiga University of Medical Science

Institute

Department

Personal name



Funding Source

Organization

Society for Research on Umami Taste

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiga University of Medical Science

Address

Setatsukinowa-cho,Otsu-shi,Shiga

Tel

0775482433

Email

ytateoka@belle.shiga-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 04 Month 01 Day

Date of IRB

2022 Year 06 Month 06 Day

Anticipated trial start date

2022 Year 09 Month 06 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 01 Month 30 Day

Last modified on

2024 Year 01 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056080


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name